1. “Hard” and “soft” lesions underlying the HLA class I alterations in cancer cells: implications for immunotherapy;Garrido;Int J Cancer,2010
2. Immune escape of melanoma: first evidence of structural alterations in two distinct components of the MHC class I antigen processing pathway;Seliger;Cancer Res,2001
3. Interferons, immunity and cancer immunoediting;Dunn;Nat Rev Immunol,2006
4. Deficiency of transporter for antigen presentation (TAP) in tumor cells allows evasion of immune surveillance and increases tumorigenesis;Johnsen;J Immunol,1999
5. Increased tumorigenicity, but unchanged immunogenicity, of transporter for antigen presentation 1-deficient tumors;Qin;Cancer Res,2002